BCM
USNA icon

BlueCrest Capital Management’s Usana Health Sciences USNA Stock Holding History

BlueCrest Capital Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4,241
Closed -$489K – 1807
2018
Q2 		$489K Buy
+4,241
New +$464K 0.01% 856
2016
Q1 		– Sell
-13,378
Closed -$855K – 1118
2015
Q4 		$855K Buy
+13,378
New +$868K 0.04% 456

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlueCrest Capital Management's USNA Position: Q3 2018 in Review

BlueCrest Capital Management sold out of Usana Health Sciences (USNA) in Q3 2018, closing a stake of 4,241 shares — an estimated $489K sold.

BlueCrest Capital Management first reported a position in USNA in Q4 2015 and held it in 2 quarters. The position peaked at $855K in Q4 2015. 197 funds tracked by Wall St. Rank hold USNA as of Q3 2018.

  • BlueCrest Capital Management reported no remaining Usana Health Sciences position as of Q3 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 4,241 Usana Health Sciences shares in Q3 2018, an estimated $489K.
  • BlueCrest Capital Management first reported a position in Usana Health Sciences in Q4 2015 and held it in 2 quarters.
  • BlueCrest Capital Management's Usana Health Sciences position peaked at $855K in Q4 2015.
  • 197 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2018.

Based on BlueCrest Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.